Kurago Biotek Overview
- Founded
-
2004
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Kurago Biotek General Information
Description
Provider of healthcare services intended to improve the quality of life and health of the people. The company's services offer pharmaceutical products as well as produce and distribute safe biotechnological foods to satisfy the current needs of the markets focused on health and wellness, enabling people to have healthier food to manage their body weight or improve their health.
Contact Information
Website
kuragobiotek.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Discovery Tools (Healthcare)
Primary Office
- Technologiehof Münster
- Mendelstraße 11
- 48149 Munster
- Germany
+49 0251 0000000
Kurago Biotek Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Jan-2011 | Completed | Generating Revenue |
Kurago Biotek Patents
Kurago Biotek Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3085702-A4 | Bioconjugate molecules with biological and techno-functional activity, method for the production thereof and use thereof | Inactive | 18-Dec-2013 | 000000000 | 0 |
| EP-3085702-A1 | Bioconjugate molecules with biological and techno-functional activity, method for the production thereof and use thereof | Inactive | 18-Dec-2013 | 000000000 | |
| US-20160310602-A1 | Bioconjugate molecules with biological and techno-functional activity, method for the production thereof and use thereof | Inactive | 18-Dec-2013 | 000000000 | 0 |
| US-20180110869-A1 | Bioconjugate molecules with biological and techno-functional activity, method for the production thereof and use thereof | Inactive | 18-Dec-2013 | 000000000 | |
| US-20190275163-A1 | Bioconjugate molecules with biological and techno-functional activity, method for the production thereof and use thereof | Inactive | 18-Dec-2013 | A61K47/61 |
Kurago Biotek Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jose Cruz | Chief Executive Officer & General Director | ||
| Damaso Acosta | Co-Founder, Chief Operating Officer & Director of Operations and Business Development |
Kurago Biotek Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Miller Center for Social Entrepreneurship | Accelerator/Incubator | 000 0000 | 000000 0 |